US Patent 12,337,024 — assignment history and current owner

US 12,337,024 · Application 17/635,441

Larazotide Formulations

Who owns US Patent 12,337,024?

US12337024 ("Larazotide Formulations") — current assignee: INTERLUDE BIOPHARMA CO.. Status: Active, estimated expiration December 25, 2040. 5 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,337,024 is INTERLUDE BIOPHARMA CO.. Based on the most recent name change record (recorded 2024-05-21).

Patent title
Larazotide Formulations
Application number
17/635,441
Apparent operating assignee
INTERLUDE BIOPHARMA CO.
Patent status
Active, estimated expiration December 25, 2040
Recorded assignments
5

Note: a security interest appears active (HIGH TRAIL SPECIAL SITUATIONS LLC) with no recorded release. Security interests reflect financing arrangements, not operating ownership.

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Apr 15, 2020Jan 25, 2023Ownership TransferMADAN, JAY P.; MUSSO, GARY F.; RADHAKRISHNAN, BALASINGHAMINNOVATE BIOPHARMACEUTICALS, INC.62479/710
Apr 30, 2020Jan 25, 2023Name ChangeINNOVATE BIOPHARMACEUTICALS, INC.9 METERS BIOPHARMA, INC.62492/981
Jul 15, 2022Apr 10, 2023Security Agreement9 METERS BIOPHARMA, INC.; NAIA RARE DISEASES, LLCHIGH TRAIL SPECIAL SITUATIONS LLC63281/653
Jan 8, 2024May 21, 2024Ownership Transfer9 METERS BIOPHARMA, INC.EBRIS PHARMA CO.67486/234
Apr 1, 2024May 21, 2024Name ChangeEBRIS PHARMA CO.INTERLUDE BIOPHARMA CO.67486/847

Scrolls sideways on narrow screens

Chain of title

In 2023, MADAN, JAY P.; MUSSO, GARY F. (+1 more) assigned the patent to INNOVATE BIOPHARMACEUTICALS, INC.. The most recent ownership transfer, recorded in 2024, lists EBRIS PHARMA CO. as assignee. In 2024, EBRIS PHARMA CO. changed its name to INTERLUDE BIOPHARMA CO.. In 2023, HIGH TRAIL SPECIAL SITUATIONS LLC recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 17/635,441 · US 12,337,024

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,337,024, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.